Breakthrough solutions to enable cost-effective and scalable cell culture

CellRev provide solutions to cell-based vaccine, therapy, and drug developers to enhance the efficiency of manufacturing processes. Our products and associated protocols address significant bottlenecks including aggregation, clumping, and cell detachment.

Solutions

Media Additives

CellRev’s proprietary media additives are designed to enhance cell culture efficiency. All products are supplied with standard protocols to aid with trial and workflow adoption.

CellRev's processing solutions increase cell yield, mitigate cell death, and permit cell detachment without impacting cell functionality.

Learn More

Proprietary Processes

CellRev leverage their proprietary solutions, in combination with the highest quality third-party equipment, to provide innovative processing platforms.

Designed to reduce costs, improve process stability and reduce product variability, our cell processing platforms translate seamlessly from research to commercial-scale manufacturing.

Learn More

Process Development

CellRev provide tailored process development services to unlock bottlenecks in adherent cell culture workflows.

In combination with the company's media additives, CellRev utilise upstream process development expertise and experience to remove bottlenecks, enhance productivity, and future-proof customer workflows.

Find out how CellRev can support your upstream process development and optimise existing workflows.

“This is an exciting and
entirely new route forward for
adherent cell culture.”

“Wow, being able to manufacture adherent cells continuously without having to adapt your cells first provides a game-changing new route for biopharmaceutical manufacturing.”

“I am impressed with the simplicity and scalability of CellRev's platform. Their core technology has the potential to be disruptive in a market that is struggling with scale. Without undermining the achievements of the team, this is a process and platform that is easy for cell therapy developers and manufacturers to adopt.”

“The CellRev team continue to drive the invention of more solutions and real unlocks to the challenge of cost-effective continuous cell culture.”